DC-mediated Homeostatic Prolif. of CD4 T Cells by TSLP

DC介导的稳态增殖。

基本信息

  • 批准号:
    6852547
  • 负责人:
  • 金额:
    $ 30.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-12-01 至 2009-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): T-cell homeostasis is critical for the adaptive immune system to respond to a variety of new pathogens and for maintaining immunological memory. It contributes to the recovery of the peripheral T-cell pool after T cell depletion caused by irradiation or viral infection. In cancer patients, homeostatic expansion of tumor-specific T cells following adoptive T cell therapy in lymphopenic cancer patients induced by chemo or radiotherapy may be beneficial for the patients to control and eliminate cancers. In HIV-infected subjects, impairment of homeostatic proliferation causes severe depletion of CD4 + T cells and disease progression to AIDS. Thymic stromal lymphopoietin (TSLP) is an IL-7-1ike cytokine. We have recently demonstrated that human TSLP strongly activated CD11c+ immature myeloid DCs (TSLP-DC). TSLP-DCs induced a strong allogeneic naive CD4+ T cell proliferation and subsequent differentiation into inflammatory TH2 cells. More recently, we found that TSLP was expressed by epithelial cells of thymus and of tonsils in the absence of allergic inflammation, suggesting that human TSLP might have additional functions. We found that TSLP activated DCs could induce a robust homeostatic proliferation of autologous naive CD4+ T cells in the absence of exogenous antigens and cytokines. This finding suggests that TSLP expressed by epithelial cells in thymus and peripheral lymphoid tissues may play a critical role in DC-mediated T cell homeostasis. The objectives of this proposal are: i) to characterize homeostatic proliferation of human naive CD4+ T cells induced by autologous TSLP-activated DCs; ii) to elucidate the molecular mechanisms underlying the ability of TSLP-activated DCs to induce homeostatic T cell proliferation; and iii) to understand why TSLP-activated DCs induce inflammatory TH2 differentiation in the allogeneic system, but homeostatic T cell proliferation in the autologous system. The specific aims in this proposal determining the function of DCs and hTSLP in the regulation of human peripheral T cell homeostasis may provide new strategies in enhancing immune responses to infectious diseases and cancer, and in controlling autoimmune diseases.
描述(由申请人提供):T细胞稳态对于适应性免疫系统响应各种新病原体和维持免疫记忆至关重要。它有助于在辐射或病毒感染引起的T细胞耗竭后恢复外周T细胞池。在癌症患者中,在由化疗或放疗诱导的淋巴细胞减少性癌症患者中的过继性T细胞疗法后肿瘤特异性T细胞的稳态扩增可能有益于患者控制和消除癌症。在HIV感染的受试者中,稳态增殖的受损导致CD 4 + T细胞的严重耗竭和疾病进展为AIDS。胸腺基质淋巴细胞生成素(Thymic stromal lymphopoietin,TSLP)是一种IL-7样细胞因子。我们最近已经证明,人TSLP强烈激活CD 11 c+未成熟髓样DC(TSLP-DC)。TSLP-DCs诱导强烈的同种异体初始CD 4 + T细胞增殖和随后分化成炎性TH 2细胞。最近,我们发现TSLP在没有过敏性炎症的情况下由胸腺和扁桃体的上皮细胞表达,这表明人TSLP可能具有额外的功能。我们发现TSLP激活的DC可以在不存在外源性抗原和细胞因子的情况下诱导自体幼稚CD 4 + T细胞的稳健的稳态增殖。这一发现表明,TSLP表达的上皮细胞在胸腺和外周淋巴组织中可能发挥关键作用DC介导的T细胞稳态。本发明的目的是:i)表征由自体TSLP活化的DC诱导的人初始CD 4 + T细胞的稳态增殖; ii)阐明TSLP活化的DC诱导稳态T细胞增殖的能力的分子机制;和iii)为了理解TSLP激活的DC在同种异体系统中诱导炎性TH 2分化的原因,而是自体系统中的稳态T细胞增殖。确定DCs和hTSLP在调节人外周T细胞稳态中的功能的具体目标可能为增强对感染性疾病和癌症的免疫应答以及控制自身免疫性疾病提供新的策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong-Jun Liu其他文献

Yong-Jun Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong-Jun Liu', 18)}}的其他基金

Understanding the early and late endosomal TLR9-mediated responses to viral DNA.
了解早期和晚期内体 TLR9 介导的病毒 DNA 反应。
  • 批准号:
    8637914
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
靶向浆细胞样树突状细胞治疗人骨髓瘤
  • 批准号:
    8721606
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Understanding the early and late endosomal TLR9-mediated responses to viral DNA.
了解早期和晚期内体 TLR9 介导的病毒 DNA 反应。
  • 批准号:
    8451259
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
靶向浆细胞样树突状细胞治疗人骨髓瘤
  • 批准号:
    8219378
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
靶向浆细胞样树突状细胞治疗人骨髓瘤
  • 批准号:
    8435365
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Understanding the early and late endosomal TLR9-mediated responses to viral DNA.
了解早期和晚期内体 TLR9 介导的病毒 DNA 反应。
  • 批准号:
    8218023
  • 财政年份:
    2012
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterizing DExD/H box helicases as viral sensors in human dendritic cells
将 DExD/H 盒解旋酶表征为人类树突状细胞中的病毒传感器
  • 批准号:
    8459503
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterizing DExD/H box helicases as viral sensors in human dendritic cells
将 DExD/H 盒解旋酶表征为人类树突状细胞中的病毒传感器
  • 批准号:
    8258739
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterizing DExD/H box helicases as viral sensors in human dendritic cells
将 DExD/H 盒解旋酶表征为人类树突状细胞中的病毒传感器
  • 批准号:
    8437349
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:
Characterizing DExD/H box helicases as viral sensors in human dendritic cells
将 DExD/H 盒解旋酶表征为人类树突状细胞中的病毒传感器
  • 批准号:
    8640881
  • 财政年份:
    2011
  • 资助金额:
    $ 30.2万
  • 项目类别:

相似国自然基金

树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
  • 批准号:
    31272541
  • 批准年份:
    2012
  • 资助金额:
    82.0 万元
  • 项目类别:
    面上项目

相似海外基金

Impacts of the migratory dendritic cells on tumor-specific T cell fate in the thymus
迁移树突状细胞对胸腺中肿瘤特异性 T 细胞命运的影响
  • 批准号:
    24K18461
  • 财政年份:
    2024
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
CAREER: Understanding the Immunometabolism-Epigenetic Crosstalk in Dendritic Cells
职业:了解树突状细胞中的免疫代谢-表观遗传串扰
  • 批准号:
    2412256
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Continuing Grant
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
  • 批准号:
    10753211
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Unified mechanism elucidation of efficacy and side effects of JAK inhibition by targeting dendritic cells
通过靶向树突状细胞抑制 JAK 的功效和副作用的统一机制阐明
  • 批准号:
    23K06897
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
  • 批准号:
    10721983
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Homeostatic maintenance and activation of dental pulp quiescent stem/progenitor cells regulated by dendritic cells and macrophages
树突状细胞和巨噬细胞调节的牙髓静止干/祖细胞的稳态维持和激活
  • 批准号:
    23H03078
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a new cancer immunotherapy using the exosome derived from neoantigen pulsed mature dendritic cells
使用源自新抗原脉冲成熟树突状细胞的外泌体开发新的癌症免疫疗法
  • 批准号:
    23K08073
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The research of targeting tumor-associated dendritic cells, a new therapy strategy by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
靶向肿瘤相关树突状细胞的研究,树突状细胞介导肿瘤相关抗原的摄取和抗肿瘤反应的新治疗策略
  • 批准号:
    23K14668
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of plasmacytoid dendritic cells in corneal immunity
浆细胞样树突状细胞在角膜免疫中的作用
  • 批准号:
    10640026
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
Ontogeny and Function of Early-Life Pulmonary Dendritic Cells
早期肺树突状细胞的个体发育和功能
  • 批准号:
    10667996
  • 财政年份:
    2023
  • 资助金额:
    $ 30.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了